$ARMK

Why is Aramark stock surging today?

Aramark (ARMK) shares rose about 8.3% after the company reported fiscal Q3 2026 adjusted EPS of $0.52 vs $0.48 consensus and revenue of $5.1B vs $4.92B forecast. Organic revenue grew 9% and adjusted operating income rose to $261M. Aramark raised FY26 organic revenue guidance to 9–10% and reaffirmed adjusted EPS growth of 20–25%.

Original reporting
Published Aug 11, 2026, 2:41 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 3:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ARMK
Bullish
high confidence
Mentioned
$ARMK
Relevance
9/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$ARMKBullishHigh
01

Why it matters

The combination of an earnings beat, a higher organic growth range, and management-provided Nexus momentum likely triggers upward revisions to FY26 estimates and improves forward sentiment.

02

Market read

Today’s move is attributed to fresh company disclosures (earnings beat plus guidance raise) rather than broad market direction.

03

What to watch

Investors may be over-weighting the beat and guidance raise relative to execution risk in scaling Nexus mobilization and securing additional colocation engagements.

Relevance 9/10Novelty 9/10Timing: pre-market results and guidance update driving the open rally

Background

The stock is reacting to fiscal Q3 2026 results released before the open, alongside a raised full-year organic revenue growth outlook and commentary on Aramark Nexus expansion.

Company-level read

Ticker impact

$ARMKBullishHigh confidence
Context

Aramark reported fiscal Q3 EPS of $0.52 vs $0.48 consensus and revenue of $5.1B vs $4.92B, then raised FY26 organic growth guidance to 9–10%.

Expected impact

Likely continued upside bias intraday and over the next few sessions as analysts update models, though momentum may fade if guidance is viewed as incremental.

Evidence & confidence

The article cites specific earnings and guidance numbers, plus Nexus expansion details that management says are excluded from FY26 guidance, creating a clear path for future upgrades.

Market effects

Positive read-through for food and facilities services demand and for tech-adjacent hospitality/workforce platforms tied to data-center capex.

Primarily US single-name impact; no meaningful macro tailwind cited.

Limited direct global spillover beyond investor sentiment toward data-center-related services.

Counterpoint

The Nexus revenue is excluded from FY26 guidance, so the upside may be more optionality than near-term earnings power.

Key entities

  • Aramark

    Reported fiscal Q3 2026 adjusted EPS and revenue beats, raised FY26 organic revenue growth guidance, and highlighted Aramark Nexus expansion.

  • Aramark Nexus

    Integrated hospitality and workforce services platform targeting hyperscale AI data centers; management says mobilization is underway at a second Texas site and a new multi-year engagement was secured.

Related articles

$ARMKMedAI 8/10

Why Aramark (ARMK) Stock Is Up Today

Aramark (NYSE: ARMK) shares rose about 9.8% after the company reported better-than-expected Q3 2026 results. Revenue was $5.06B, up 9.3% year over year, and adjusted EPS was $0.52 above consensus. Free cash flow turned positive at $8.69M versus a $33.55M loss a year earlier, supporting investor sentiment.

$ARMKMed

Aramark Boosts FY26 Organic Revenue Growth - Update

Aramark (ARMK) reported third-quarter results and reaffirmed its FY2026 adjusted EPS growth outlook of 20% to 25%. It raised its FY2026 organic revenue growth forecast to 9% to 10% from the prior high-end 7% to 9%. The board approved a $0.12 quarterly dividend payable Sept. 9, 2026. ARMK was about $55 premarket.

$ARMKMed

Aramark (NYSE:ARMK) Surprises With Q2 CY2026 Sales

Aramark (NYSE:ARMK) reported Q2 CY2026 revenue of $5.06 billion, up 9.3% year over year and 2.4% above Wall Street estimates, according to the company. Non-GAAP adjusted EPS was $0.52, up from $0.40 a year earlier, beating consensus by 7.2%. Analysts expect full-year EPS to rise to $2.57 from $2.09.

$ARMKHigh

Aramark (ARMK): Results of Operations and Financial Condition

Aramark (ARMK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991armkq3fy2026.htm EX-99.1 Document For Immediate Release Inquiries: Felise Glantz Kissell (215) 409-7287 Kissell-Felise@aramark.com Gene Cleary (215) 409-7945 Cleary-Gene@aramark.com Aramark Reports Third Quarter Earnings YEAR-OVER-YEAR SUMMARY Note: As previously d

$ARMKMedAI 8/10

Aramark (ARMK) – Investment Analysts’ Weekly Ratings Updates

Aramark (NYSE: ARMK) saw multiple brokerages update ratings and price targets from mid-March to mid-May 2026. Bank of America raised its target to $59 (buy); RBC to $55 (outperform); Morgan Stanley to $50 (equal weight); UBS to $56 (buy); JPMorgan to $55 (overweight). Several others reaffirmed “buy” ratings. Aramark also declared a $0.12 quarterly dividend (ex-date May 20), $0.48 annualized, ~0.9% yield.